Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M16,389Revenue $M3,013Net Margin (%)-21.0Altman Z-Score1.3
Enterprise Value $M19,289EPS $-3.8Operating Margin %-11.9Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.3Pre-tax Margin (%)-20.9Higher ROA y-yY
Price/Book2.710-y EBITDA Growth Rate %--Quick Ratio2.0Cash flow > EarningsY
Price/Sales4.35-y EBITDA Growth Rate %--Current Ratio2.2Lower Leverage y-yY
Price/Free Cash Flow48.3y-y EBITDA Growth Rate %--ROA % (ttm)-5.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-17.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M208ROIC % (ttm)-9.1Gross Margin Increase y-yN

Gurus Latest Trades with ENDP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENDPWallace Weitz 2015-06-30 Add0.48%$78.39 - $95.92
($86.4)
$ 78.70-9%Add 28.57%961,135
ENDPSteve Mandel 2015-06-30 Add0.09%$78.39 - $95.92
($86.4)
$ 78.70-9%Add 9.17%3,570,117
ENDPGeorge Soros 2015-06-30 Add0.07%$78.39 - $95.92
($86.4)
$ 78.70-9%Add 3.73%2,299,781
ENDPJoel Greenblatt 2015-06-30 Buy 0.01%$78.39 - $95.92
($86.4)
$ 78.70-9%New holding11,516
ENDPMario Gabelli 2015-06-30 Add$78.39 - $95.92
($86.4)
$ 78.70-9%Add 2.73%15,050
ENDPSteve Mandel 2015-03-31 Buy 1.11%$71.97 - $92.37
($83.64)
$ 78.70-6%New holding3,270,117
ENDPGeorge Soros 2015-03-31 Add0.47%$71.97 - $92.37
($83.64)
$ 78.70-6%Add 26.79%2,217,176
ENDPWallace Weitz 2015-03-31 Reduce-0.04%$71.97 - $92.37
($83.64)
$ 78.70-6%Reduce 2.61%747,530
ENDPDodge & Cox 2015-03-31 Buy $71.97 - $92.37
($83.64)
$ 78.70-6%New holding2,560
ENDPMario Gabelli 2015-03-31 Reduce$71.97 - $92.37
($83.64)
$ 78.70-6%Reduce 26.38%14,650
ENDPGeorge Soros 2014-12-31 Buy 1.4%$60.19 - $73.37
($68.57)
$ 78.7015%New holding1,748,729
ENDPJulian Robertson 2014-12-31 Sold Out -0.37%$60.19 - $73.37
($68.57)
$ 78.7015%Sold Out0
ENDPJoel Greenblatt 2014-12-31 Sold Out -0.01%$60.19 - $73.37
($68.57)
$ 78.7015%Sold Out0
ENDPWallace Weitz 2014-09-30 Reduce-0.34%$61.26 - $70.27
($65.73)
$ 78.7020%Reduce 17.65%721,950
ENDPJoel Greenblatt 2014-09-30 Reduce-0.07%$61.26 - $70.27
($65.73)
$ 78.7020%Reduce 84.54%13,716
ENDPSteve Mandel 2014-06-30 Sold Out -1.2%$56.28 - $73.94
($66.81)
$ 78.7018%Sold Out0
ENDPWallace Weitz 2014-06-30 Add0.81%$56.28 - $73.94
($66.81)
$ 78.7018%Add 75.01%876,670
ENDPGeorge Soros 2014-06-30 Sold Out -0.13%$56.28 - $73.94
($66.81)
$ 78.7018%Sold Out0
ENDPJoel Greenblatt 2014-06-30 Buy 0.08%$56.28 - $73.94
($66.81)
$ 78.7018%New holding88,697
ENDPMario Gabelli 2014-06-30 Reduce$56.28 - $73.94
($66.81)
$ 78.7018%Reduce 21.77%23,900
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ENDP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ENDP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HIGGINS ARTHUR JDirector 2015-06-16Buy2,500$81.1-2.96view
MANOGUE CAROLINE BExec. V.P.,Chief Legal Officer 2015-04-08Sell105,562$91.9-14.36view
Farhat CamillePresident, AMS, Inc. 2015-03-10Sell8,650$89.39-11.96view
Farhat CamillePresident, AMS, Inc. 2015-03-09Sell40,438$87.02-9.56view
MANOGUE CAROLINE BExec. V.P.,Chief Legal Officer 2015-03-05Sell42,033$87.78-10.34view
Lortie BrianPresident Branded Pharma 2015-03-04Sell5,800$85.35-7.79view
Upadhyay SuketuEVP, CFO 2014-11-14Buy3,700$66.9417.57view
HIGGINS ARTHUR JDirector 2014-08-05Buy3,500$65.6519.88view
DELUCCA JOHNDirector 2014-06-09Sell6,764$68.8314.34view
MANOGUE CAROLINE BExec. V.P., CLO & Secy 2014-05-29Sell175,033$72.029.28view

Quarterly/Annual Reports about ENDP:

    News about ENDP:

    Articles On GuruFocus.com
    Mandel’s Lone Pine Takes Stake in Growing Horizon Pharma Jul 28 2015 
    John Griffin Shows Stake in Trendy Fitbit Inc. Jun 30 2015 
    Dodge & Cox Buys 2 New Stocks Jun 10 2015 
    Endo International Acquires Par Pharmaceuticals For $8 Billion May 21 2015 
    Endo International Posts Upbeat Q1 Results May 13 2015 
    Endo Pharmaceuticals Posts A Solid Q1 Earnings Report May 12 2015 
    Weitz Value Fund First Quarter 2015 Commentary Apr 20 2015 
    Weekly Insider Sells Highlight: ANTM, ENDP, QVCA, TOL Apr 12 2015 
    Valeant Finally Bags Salix for $11 Billion Apr 06 2015 
    This Week’s Pharma Highlights Mar 19 2015 

    More From Other Websites
    Drug Deal Valuations Soar as Par Gains 300%: Real M&A Aug 26 2015
    Pharmaceutical Stocks Affect the iShares NASDAQ Biotechnology ETF Aug 25 2015
    ENDO INTERNATIONAL PLC Financials Aug 20 2015
    Endo Gets Favorable Ruling Related to Opana ER in U.S. Aug 17 2015
    Court ruling upholds Endo pain product patents Aug 17 2015
    Top Mid-Cap Stocks Smart Money Love: Cheniere Energy Inc. (LNG), Liberty Interactive Corporation... Aug 17 2015
    Endo Wins Order Blocking Generic of Opana ER Until 2023 Aug 14 2015
    Endo Announces U.S. District Court Ruling Upholding OPANA® ER Intellectual Property Aug 14 2015
    Endo Announces U.S. District Court Ruling Upholding OPANA® ER Intellectual Property Aug 14 2015
    Endo Announces U.S. District Court Ruling Upholding OPANA® ER Intellectual Property Aug 14 2015
    Endo Announces Appearance at Canaccord Genuity 35th Annual Growth Conference Aug 11 2015
    Endo Announces Appearance at Canaccord Genuity 35th Annual Growth Conference Aug 11 2015
    Endo Announces Appearance at Canaccord Genuity 35th Annual Growth Conference Aug 11 2015
    4 More Biotechs Leerink Is Looking At Post-Earnings Aug 11 2015
    Company News for August 11, 2015 - Corporate Summary Aug 11 2015
    Endo Q2 Earnings Beat Estimates, But Guidance On Hold Aug 10 2015
    Edited Transcript of ENDP earnings conference call or presentation 10-Aug-15 12:00pm GMT Aug 10 2015
    Endo reports 2Q loss Aug 10 2015
    Endo reports 2Q loss Aug 10 2015
    Endo Beats on Q2 Earnings and Revenues, Maintains View - Analyst Blog Aug 10 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK